- Q1 2024 DiaSorin SpA Earnings Call TranscriptMay 10, 2024$107.4Earnings
- Q3 2023 DiaSorin SpA Earnings Call TranscriptNov 03, 2023$87.45Earnings
- Half Year 2023 DiaSorin SpA Earnings Call TranscriptJul 27, 2023$96Earnings
- Q1 2023 DiaSorin SpA Earnings Call TranscriptMay 09, 2023$119.74Earnings
- Full Year 2022 DiaSorin SpA Earnings Call TranscriptMar 27, 2023$111.33Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Q3 2022 DiaSorin SpA Earnings Call TranscriptOct 27, 2022$107Earnings
- Q2 2022 DiaSorin SpA Earnings Call TranscriptAug 03, 2022$144.11Earnings
- Q1 2022 DiaSorin SpA Earnings Call TranscriptMay 06, 2022$129Earnings
- Q4 2021 DiaSorin SpA Earnings Call TranscriptMar 16, 2022$130Earnings
- DiaSorin SpA Investor Day TranscriptDec 17, 2021
- Q3 2021 DiaSorin SpA Earnings Call TranscriptNov 11, 2021$220.95Earnings
- Q2 2021 DiaSorin SpA Earnings Call TranscriptJul 30, 2021$203.44 (+1.72%)Earnings
- Q1 2021 DiaSorin SpA Earnings Call TranscriptMay 14, 2021$173.25Earnings
- DiaSorin SpA to Acquire Luminex Corp Call TranscriptApr 12, 2021
- Q4 2020 DiaSorin SpA Earnings Call TranscriptMar 11, 2021$219Earnings
- Q3 2020 DiaSorin SpA Earnings Call TranscriptNov 11, 2020$183Earnings
- Q2 2020 DiaSorin SpA Earnings Call TranscriptJul 30, 2020$202.18Earnings
- Q1 2020 DiaSorin SpA Earnings Call TranscriptMay 13, 2020$169.66Earnings
- Q4 2019 DiaSorin SpA Earnings Call TranscriptMar 11, 2020$118.43 (-3.34%)Earnings
- Q3 2019 DiaSorin SpA Earnings Call TranscriptNov 06, 2019$114.75Earnings
- Q2 2019 DiaSorin SpA Earnings Call TranscriptJul 31, 2019$114.75Earnings
- DiaSorin SpA Investor Day TranscriptJun 11, 2019
- Q1 2019 DiaSorin SpA Earnings Call TranscriptMay 09, 2019$100.1Earnings
- Q4 2018 DiaSorin SpA Earnings Call TranscriptMar 14, 2019$95.67Earnings
Q4 2021 DiaSorin SpA Earnings Call Transcript
Good afternoon, this is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin Full Year 2021 Results Conference Call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Carlo Rosa, Chief Executive Officer of DiaSorin. Please go ahead, sir.
Thank you, operator. Good morning, good afternoon to everybody, and welcome to the year-end results call for DiaSorin.
I'm going to briefly comment quarter 4. As usual at constant exchange rate 2020 and then Mr. Pedron will take you through the numbers. It is noteworthy that Q4 represented a full recovered quarter from a revenue perspective. So it's very interesting that we are going to be -- I will compare results to Q4 of last year.
And this will, in my opinion, give an indication of how the business is performing. Starting from this quarter, after the Luminex acquisition, I will provide comments in 3 different buckets that now we are using to represent the business, so 2
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)